title: Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence.
abstract: The identification of reliable transcriptome biomarkers requires the simultaneous consideration of regulatory and target elements including microRNAs (miRNAs), transcription factors (TFs), and target genes. A novel approach that integrates multivariate survival analysis, feature selection, and regulatory network visualization was used to identify reliable biomarkers of ovarian cancer survival and recurrence. Expression profiles of 799 miRNAs, 17,814 TFs and target genes and cohort clinical records on 272 patients diagnosed with ovarian cancer were simultaneously considered and results were validated on an independent group of 146 patients. Three miRNAs (hsa-miR-16, hsa-miR-22*, and ebv-miR-BHRF1-2*) were associated with both ovarian cancer survival and recurrence and 27 miRNAs were associated with either one hazard. Two miRNAs (hsa-miR-521 and hsa-miR-497) were cohort-dependent, while 28 were cohort-independent. This study confirmed 19 miRNAs previously associated with ovarian cancer and identified two miRNAs that have previously been associated with other cancer types. In total, the expression of 838 and 734 target genes and 12 and eight TFs were associated (FDR-adjusted P-value <0.05) with ovarian cancer survival and recurrence, respectively. Functional analysis highlighted the association between cellular and nucleotide metabolic processes and ovarian cancer. The more direct connections and higher centrality of the miRNAs, TFs and target genes in the survival network studied suggest that network-based approaches to prognosticate or predict ovarian cancer survival may be more effective than those for ovarian cancer recurrence. This study demonstrated the feasibility to infer reliable miRNA-TF-target gene networks associated with survival and recurrence of ovarian cancer based on the simultaneous analysis of co-expression profiles and consideration of the clinical characteristics of the patients.
authors.affiliation: Department of Animal Sciences, University of Illinois, Urbana, Illinois, USA.
authors.forename: Kristin R
authors.initials: KR
authors.lastname: Delfino
authors.forename: Sandra L
authors.initials: SL
authors.lastname: Rodriguez-Zas
mesh_terms: D014408:Biomarkers, Tumor / Q000096:biosynthesis / Q000235:genetics; D015331:Cohort Studies; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D053263:Gene Regulatory Networks; D052138:Genes, Neoplasm; D006801:Humans; D035683:MicroRNAs; D009364:Neoplasm Recurrence, Local / Q000235:genetics / Q000378:metabolism / Q000401:mortality / Q000473:pathology; D010051:Ovarian Neoplasms / Q000235:genetics / Q000378:metabolism / Q000401:mortality / Q000473:pathology; D012334:RNA, Neoplasm / Q000096:biosynthesis / Q000235:genetics; D015996:Survival Rate
chemical_list: D014408:Biomarkers, Tumor; D035683:MicroRNAs; D012334:RNA, Neoplasm
references.citation: J Hum Genet. 2000;45(3):192-5
references.pmid: 10807548
references.citation: Int J Cancer. 2011 Oct 1;129(7):1624-34
references.pmid: 21128228
references.citation: Gynecol Oncol. 2009 Sep;114(3):457-64
references.pmid: 19501389
references.citation: Mol Cancer. 2008 Apr 28;7:35
references.pmid: 18442408
references.citation: PLoS One. 2008 Jun 18;3(6):e2436
references.pmid: 18560586
references.citation: Cancer Res. 2002 Jan 1;62(1):48-52
references.pmid: 11782357
references.citation: Oncol Rep. 2007 Oct;18(4):769-74
references.pmid: 17786334
references.citation: Pathol Res Pract. 2008;204(11):823-30
references.pmid: 18774655
references.citation: BMC Bioinformatics. 2007 Nov 02;8:426
references.pmid: 17980028
references.citation: N Engl J Med. 2009 Mar 19;360(12):1200-10
references.pmid: 19246354
references.citation: J Pain Symptom Manage. 2010 May;39(5):839-46
references.pmid: 20471545
references.citation: Int J Gynecol Cancer. 2005 Sep-Oct;15(5):878-83
references.pmid: 16174239
references.citation: J Pathol. 2009 Oct;219(2):214-21
references.pmid: 19593777
references.citation: J Biol Chem. 2004 Mar 5;279(10):8567-76
references.pmid: 14676209
references.citation: Cancer Res. 2008 Jan 15;68(2):425-33
references.pmid: 18199536
references.citation: Methods Mol Biol. 2009;563:219-39
references.pmid: 19597788
references.citation: Br J Cancer. 2008 Oct 21;99(8):1269-75
references.pmid: 18854825
references.citation: Oncogene. 2008 May 8;27(21):3021-31
references.pmid: 18059336
references.citation: J Cancer Res Clin Oncol. 1994;120(12):717-22
references.pmid: 7798296
references.citation: Endocr Relat Cancer. 2010 Jan 29;17(1):F77-89
references.pmid: 19903743
references.citation: Clin Cancer Res. 2008 May 1;14(9):2690-5
references.pmid: 18451233
references.citation: Oncogene. 2003 Apr 10;22(14):2172-85
references.pmid: 12687019
references.citation: Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9136-41
references.pmid: 16754881
references.citation: Cancer Res. 2006 Sep 1;66(17):8404-12
references.pmid: 16951150
references.citation: Cancer Res. 2012 May 1;72(9):2294-303
references.pmid: 22396495
references.citation: Oncogene. 2001 Jul 27;20(33):4457-65
references.pmid: 11494141
references.citation: Ann Surg Oncol. 2012 Jul;19(7):2394-402
references.pmid: 22407312
references.citation: BMC Res Notes. 2012 Mar 27;5:164
references.pmid: 22452920
references.citation: Lancet Oncol. 2011 Mar;12(3):273-85
references.pmid: 21345725
references.citation: Ann N Y Acad Sci. 2004 Jun;1022:44-9
references.pmid: 15251938
references.citation: Am J Obstet Gynecol. 2003 Jul;189(1):22-7
references.pmid: 12861133
references.citation: Mol Cancer Res. 2008 May;6(5):695-705
references.pmid: 18505915
references.citation: Nucleic Acids Res. 2010 Jul;38(Web Server issue):W210-3
references.pmid: 20478823
references.citation: Cancer Res. 2007 Sep 15;67(18):8699-707
references.pmid: 17875710
references.citation: Mol Cell Biol. 2003 May;23(9):3043-51
references.pmid: 12697807
references.citation: Int J Mol Med. 2004 Mar;13(3):413-7
references.pmid: 14767572
references.citation: Clin Cancer Res. 2011 Mar 1;17(5):1065-74
references.pmid: 21123456
references.citation: N Engl J Med. 2005 Oct 27;353(17):1768-71
references.pmid: 16251533
references.citation: Int J Oncol. 2003 Nov;23(5):1451-9
references.pmid: 14532990
references.citation: BMC Med Genomics. 2011 Jun 07;4:49
references.pmid: 21649900
references.citation: Histol Histopathol. 2006 Oct;21(10):1055-64
references.pmid: 16835828
references.citation: BMC Bioinformatics. 2011 Mar 04;12:67
references.pmid: 21375730
references.citation: Oncogene. 2008 Apr 17;27(18):2575-82
references.pmid: 17998940
references.citation: Oncol Rep. 2012 Feb;27(2):447-54
references.pmid: 21971665
references.citation: Future Oncol. 2009 Dec;5(10):1641-57
references.pmid: 20001801
references.citation: Neuropeptides. 2010 Feb;44(1):31-44
references.pmid: 20006904
references.citation: Clin Cancer Res. 2007 Oct 1;13(19):5745-55
references.pmid: 17908964
references.citation: Cancer Res. 2008 Dec 15;68(24):10307-14
references.pmid: 19074899
references.citation: J Biol Chem. 2008 Aug 29;283(35):23567-80
references.pmid: 18586674
references.citation: Cancer Sci. 2011 Mar;102(3):522-9
references.pmid: 21166959
references.citation: Curr Genomics. 2009 Mar;10(1):35-41
references.pmid: 19721809
references.citation: Proc Natl Acad Sci U S A. 2008 May 13;105(19):7004-9
references.pmid: 18458333
references.citation: Cancer Res. 2010 Feb 15;70(4):1459-68
references.pmid: 20124474
references.citation: Cancer Sci. 2008 Dec;99(12):2365-72
references.pmid: 19032364
references.citation: Br J Cancer. 2003 Jul 21;89(2):232-8
references.pmid: 12865907
references.citation: Cancer Res. 2005 Jun 15;65(12):5112-22
references.pmid: 15958555
references.citation: J Natl Cancer Inst. 2006 Aug 2;98(15):1060-7
references.pmid: 16882943
references.citation: Anticancer Res. 2002 Nov-Dec;22(6C):3963-70
references.pmid: 12553019
references.citation: Nature. 2008 Oct 23;455(7216):1061-8
references.pmid: 18772890
references.citation: Gynecol Oncol. 2009 May;113(2):249-55
references.pmid: 19237188
references.citation: PLoS One. 2009;4(4):e5311
references.pmid: 19390579
references.citation: Oncogene. 2006 Feb 9;25(6):888-98
references.pmid: 16186795
references.citation: Cancer Causes Control. 2009 Feb;20(1):47-55
references.pmid: 18704709
references.citation: Cancer Genomics Proteomics. 2011 Jul-Aug;8(4):173-83
references.pmid: 21737610
references.citation: Genes Dev. 2011 Nov 1;25(21):2227-41
references.pmid: 22056668
references.citation: Nucleic Acids Res. 2000 Jan 1;28(1):27-30
references.pmid: 10592173
references.citation: Gynecol Oncol. 2009 Aug;114(2):253-9
references.pmid: 19446316
references.citation: Brief Bioinform. 2012 Mar;13(2):150-61
references.pmid: 21622543
references.citation: Biom J. 2007 Aug;49(5):719-30
references.pmid: 17638295